Buch


Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

Yosef Yarden; Moshe Elkabets (Hrsg.)

 

160,49 EUR
Lieferzeit 12-13 Tage



160,49 EUR
Lieferzeit 12-13 Tage



Autorinformation
Inhaltsverzeichnis


Übersicht


Verlag : Springer International Publishing
Buchreihe : Resistance to Targeted Anti-Cancer Therapeutics
Sprache : Englisch
Erschienen : 02. 02. 2019
Seiten : 242
Einband : Kartoniert
Höhe : 235 mm
Breite : 155 mm
Gewicht : 409 g
ISBN : 9783030098179
Sprache : Englisch

Du und »Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways«




Autorinformation


Yosef Yarden, PhD, is Professor, Department of Biological Regulation, The Weizmann Institute of Science, Israel.

Inhaltsverzeichnis


Resistance of colorectal tumors to anti-EGFR antibodies.- Resistance of lung cancer to kinase inhibitors specific to EGFR or ALK.- Mechanisms of action and resistance of trastuzumab in breast cancer.- Mechanisms of resistance to molecular therapies targeting the HGF/MET axis.- RAF, MEK and ERK inhibitors as anti-cancer drugs: intrinsic and acquired resistance as a major therapeutic challenge.- Mechanisms of resistance to PI3K and AKT inhibitors.- Sensitivity and resistance to BH3 mimetics in cancer therapy.- Resistance mechanisms to cyclin-dependent kinase inhibitors.- Resistance to inhibitors of angiogenesis.

Deine Buchhandlung


Buchhandlung LeseLust
Inh. Gernod Siering

Georgenstraße 2
99817 Eisenach

03691/733822
kontakt@leselust-eisenach.de

Montag-Freitag 9-17 Uhr
Sonnabend 10-14 Uhr



Deine Buchhandlung
Buchhandlung LeseLust
Inh. Gernod Siering

Georgenstraße 2
99817 Eisenach

03691/733822
kontakt@leselust-eisenach.de

Montag-Freitag 9-17 Uhr
Sonnabend 10-14 Uhr